Keyphrases
Bladder
5%
Bowel
5%
Brachytherapy
5%
Cause-specific Survival
10%
Cervical Cancer
5%
Cervical Cancer Patients
10%
Clinical Outcomes
100%
Common Terminology Criteria for Adverse Events (CTCAE)
5%
Concurrent Chemotherapy
5%
CT Simulation
5%
CT-guided
5%
Cumulative Hazard Function
5%
Curative Intent
5%
External Irradiation
5%
F-18 Fluorodeoxyglucose Positron Emission Tomography
5%
FDG PET-CT
10%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Function Analysis
5%
Histology
5%
Improved Survival
5%
Intensity-modulated Radiation Therapy
100%
Locally Advanced Cervical Cancer
100%
Newly Diagnosed
5%
PET Response
5%
Prospective Cohort Study
5%
Radiation Intensity
10%
Radiation Therapy
5%
Radiotherapy
5%
Recurrence Risk
5%
Recurrence-free Survival
5%
Stage Distribution
5%
Statistical Significance
5%
Therapy Groups
10%
Toxicity Outcomes
5%
Treatment Response
5%
Treatment Toxicity
5%
Medicine and Dentistry
Adverse Event
5%
Bladder
5%
Brachytherapy
5%
Cause Specific Survival
10%
Cervical Cancer
100%
Chemotherapy
5%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
5%
Intensity Modulated Radiation Therapy
100%
Polyethylene Terephthalate
15%
Positron Emission Tomography
100%
Positron Emission Tomography-Computed Tomography
10%
Prospective Cohort Study
5%
Radiation Therapy
5%
Recurrence Free Survival
5%
Recurrence Risk
5%
Recurrent Disease
5%
Treatment Response
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Cause Specific Survival
40%
Chemotherapy
20%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
20%
Polyethylene Terephthalate
100%
Prospective Cohort Study
20%
Recurrence Free Survival
20%
Recurrence Risk
20%
Recurrent Disease
20%
Uterine Cervix Cancer
100%
Biochemistry, Genetics and Molecular Biology
Cause Specific Survival
100%
Nomenclature
50%
Positron Emission Tomography
100%
Positron Emission Tomography-Computed Tomography
100%
Prospective Cohort Study
50%
Recurrence Free Survival
50%